SCHEMBL22354568

SCHEMBL22354568

CCC(=O)OC(COCCCCOCC(CN1CCOCC1)OC(=O)CC)CN1CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
USP2 O75604 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
THRB P10828 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
ABCB1 P08183 1/20 0.38
TLR2 O60603 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.37
NPC1 O15118 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 1/20 0.37
THRA P10827 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22354570 0.85 ALDH1A1 (0.41) ALDH1A1USP2KDM4EALOX15SMN1; SMN2
SCHEMBL25587776 0.83 ALDH1A1 (0.43) ALDH1A1USP2KDM4EALOX15SMN1; SMN2
SCHEMBL23869628 0.81 TLR2 (0.38) ALDH1A1USP2KDM4EALOX15SMN1; SMN2
SCHEMBL18751382 0.77 ALDH1A1 (0.41) ALDH1A1USP2KDM4ESMN1; SMN2ABCB1
SCHEMBL15025393 0.74 PDE4A (0.41) ALDH1A1USP2KDM4EALOX15MEN1
SCHEMBL15025259 0.74 TLR2 (0.36) ALDH1A1USP2KDM4EALOX15SMN1; SMN2
SCHEMBL29321107 0.73 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2LMNATLR2
SCHEMBL29321098 0.73 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2LMNATLR2
SCHEMBL8014369 0.73 ALDH1A1 (0.49) ALDH1A1LMNATHRBMAPTTLR2
SCHEMBL8014365 0.73 ALDH1A1 (0.49) ALDH1A1LMNATHRBMAPTTLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159581-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS SYNOVO GMBH (DE) 2023-05-25 US disclosed
US-20230159581-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS SYNOVO GMBH (DE) 2023-05-25 US disclosed
US-20230131943-A1 ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS BURNET MICHEAL W (DE) 2023-04-27 US disclosed
US-20230131943-A1 ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS BURNET MICHEAL W (DE) 2023-04-27 US disclosed
WO-2021195126-A1 ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS BURNET MICHAEL W (DE) 2021-09-30 WO disclosed
US-20200262857-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS SYNOVO GMBH (DE) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131943-A1 ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS CTSA, GAA, SLC7A5 ALDH1A1 3317/4885USP2 571/4885KDM4E 3394/4885
US-20230159581-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS CTSA, ALOX15, ALOX5 ALDH1A1 947/4885USP2 928/4885KDM4E 3648/4885
US-20200262857-A1 NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS CTSA, ALOX15, ALOX5 ALDH1A1 947/4885USP2 928/4885KDM4E 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.